I took part in this debate last week at Johns Hopkins, as part of their Business of Health Initiative. I'll be back with some follow up thoughts on the day's…
The New York Times Editorial Board has revisited its early enthusiasm for marijuana legalization and now calls for stronger regulation — including significantly higher taxes. Some of the proposals are…
The unionization effort at Sheri’s Ranch underscores a structural feature of taboo but legal industries: fragility. Organizers quoted in press reports describe reluctance to “rock the boat,” given fears that…
This week’s Taboo & Repugnant Roundup opens with a close reading of a recent Wall Street Journal essay on vice and prohibition. The discussion focuses on how the piece frames…
My guests today are Andrew Gilden, Southwestern Law School, and Sarah R. Wasserman Rajec, William & Mary Law School. They join me today to discuss their recent paper, Patenting the…
This week’s Taboo & Repugnant Roundup engages three distinct items that surface recurring anxieties about morally charged exchanges. The post opens with a critical response to a recent guest essay…
A new edited volume, Markets in Human Organs for Transplantation: Controversy and Contention (James Stacey Taylor & Mark Cherry, eds.), is now available in hardcover and ebook. The book revisits…
Debates over paid plasma donation tend to cycle through familiar frames: altruistic gift, moral corruption, or exploitation of the vulnerable. This post steps back and asks a different question: what…
This week’s roundup spans symbolic honors, moral limits of markets, and biomedical supply chains. It opens with the Nobel Committee’s statement reaffirming the inalienability of the Nobel Prize after Trump-related…
The latest Taboo & Repugnant Roundup includes three items that span organ transplantation, end-of-life law, and the classroom. First is further discussion of the New York Times profile of the…